What is anisocytosis
Anisocytosis means abnormal variation in size of the red blood cells population present on a blood smear slide under light microscopy. Anisocytosis is a measure of red blood cell size variability and is quantified with red cell distribution width (RDW), which is a measure of red cell size variation. Red cell distribution width (RDW) represents the coefficient of variation of the red blood cell volume distribution (size) and is expressed as a percentage. The normal value for RDW is 13 ± 1.5% 1).
Poikilocytosis means unusual variation in red blood cells shape 2). From a diagnostic standpoint, poikilocytosis has no specificity, but the recognition of specific forms of poikilocytes (irregularly shaped cells) often points to specific disorders. Examination of peripheral blood films of normal persons reveals small numbers of poikilocytes, usually less than 2%. In the assessment of the significance of poikilocytosis, one must identify the predominant abnormal morphologic form and exclude artifactual alterations of the red cells. Spherocytes are round, densely staining red cells that lack central pallor and have a smaller than normal diameter. In stomatocytes, the area of central pallor is elliptical rather than round, giving the cell the appearance of the opening of a mouth (stoma). Target cells (codocytes) have a centrally located disk of hemoglobin surrounded by an area of pallor with an outer rim of hemoglobin adjacent to the cell membrane giving the cell the appearance of a target. Leptocytes (or wafer cells) are thin, flat cells with the hemoglobin at the periphery of the cell. Sickle cells (drepanocytes) are elongated, sometimes crescent-shaped, erythrocytes with pointed ends. Elliptocytes (ovalocytes) range from slightly oval to elongated cigar-shaped forms. Teardrop erythrocytes (dacryocytes) are red cells with one end round and the other end more pointed. Acanthocytes have several (usually 3 to 7) irregularly spaced blunted projections from the margin of the cells. Echinocytes are also cells with cytoplasmic projections, but in contrast to acanthocytes, the projections are typically evenly spaced on the cell surface, more numerous (often 10 to 15), and frequently have sharper points. Schizocytes (schistocytes) are fragmented erythrocytes appearing in a variety of morphologic forms such as small triangular erythrocytes, helmet cells, and normal-size erythrocytes with 2 to 3 pointed surface projections (keratocytes, or “horn cells”). Round erythrocytes with a single, elliptical or round surface defect are termed bite cells. Rouleaux formation is a phrase denoting the stacking of erythrocytes, generally in a curving pattern.
During erythropoiesis, the process of erythroid maturation involves a progressive condensation of nuclear chromatin (termed nuclear maturation) and finally its extrusion from the cell, the synthesis of hemoglobin in the cytoplasm (termed cytoplasmic maturation), and a concomitant reduction in cell size due to division and water loss.
Defects in nuclear maturation, as seen in megaloblastic anemias due to folate or B12 deficiency, result in large oval erythrocytes (macroovalocytes) with a normal hemoglobin content. The mean corpuscular volume (MCV) and mean corpuscular hemoglobin (MCH) are increased, while the mean corpuscular hemoglobin concentration (MCHC) remains normal. There is anisocytosis, and red cell distribution width is often increased. In the macrocytosis of liver disease, where there is no defect in nuclear maturation, the cells are large due to an excess red cell membrane. These cells are round, rather than oval, and the red cell distribution width is normal.
Red blood cell indices:
- Mean corpuscular volume (MCV) defines the size of the red blood cells and is expressed as femtoliters (10−15; fl) or as cubic microns (μm3). The normal values for MCV are 87 ± 7 fl.
- Mean corpuscular hemoglobin (MCH) quantifies the amount of hemoglobin per red blood cell. The normal values for MCH are 29 ± 2 picograms (pg) per cell.
- Mean corpuscular hemoglobin concentration (MCHC) indicates the amount of hemoglobin per unit volume. In contrast to mean corpuscular hemoglobin (MCH), MCHC correlates the hemoglobin content with the volume of the cell. It is expressed as g/dl of red blood cells or as a percentage value. The normal values for mean corpuscular hemoglobin concentration (MCHC) are 34 ± 2 g/dl.
Defective hemoglobin synthesis results in small cells (low MCV) with or without anisocytosis. In heterozygous β-thalassemias, the cells are uniformly small (low MCV; red cell distribution width tends to be normal), whereas in iron deficiency, anisocytosis (increased red cell distribution width) may be the first laboratory abnormality, even before anemia and microcytosis are seen.
In abnormalities involving nuclear maturation, hemoglobin production proceeds normally, while cell division lags behind, ultimately leading to a larger than normal cell. In contrast, when there is defective and delayed synthesis of hemoglobin, the continued cell division leads to microcytosis.
Red blood cells size, distribution and shape variation can all be clues to clinical disease and pathologic processes. However, it should be noted that red cell indices (e.g. MCV, MCH, MCHC), red cell distribution width (RDW), and red blood cell histograms will not help identify conditions such as red cell inclusions (e.g., malarial parasites) or membrane abnormalities such as spherocytosis that might be responsible for the anemia.
Anemias are classified, according to the size of the red blood cell, as being normocytic (normal MCV), macrocytic (increased MCV), or microcytic (decreased MCV). Microcytic anemias were also often described as being hypochromic based on peripheral smear examination and MCHC when this value was determined manually. MCHC as measured by the electronic machines is mostly normal in microcytic anemias, however, and the value of MCH closely parallels the value of MCV. The optical properties of the small, thin microcytes make them appear hypochromic on the blood smear, while the hemoglobin concentration remains in the normal range (microcytic, normochromic anemias).
The general availability of red cell distribution width as a measure of anisocytosis helps further in the evaluation of anemias based on morphology. Significant anisocytosis often leads to an increased red cell distribution width, whereas in its absence the red cell distribution width remains normal.
Anisocytosis is identified by red cell distribution width (RDW) and is classified according to the size of red blood cell measured by mean corpuscular volume (MCV). According to this, it can be divided into:
- Anisocytosis with microcytosis – Iron deficiency, sickle cell anemia. A predominance of hypochromic microcytic cells is found in iron deficiency anemia, thalassemia, and hereditary sideroblastic anemia, and in some patients with the anemia of chronic disorders and with lead intoxication. For individuals with mild anemia, the degree of microcytosis is usually substantially greater in patients with thalassemia minor than those with iron deficiency. Anisochromia with the presence of a dimorphic red cell population (hypochromic and normochromic) is observed in acquired sideroblastic anemia, patients with thalassemia minor after transfusions, and persons with iron deficiency following transfusions or treatment with iron.
- Anisocytosis with macrocytosis – Folate or vitamin B12 deficiency, autoimmune hemolytic anemia, cytotoxic chemotherapy, chronic liver disease, myelodysplastic syndrome. Macrocytes (frequently oval) in substantial numbers are observed in patients with megaloblastic anemias (vitamin B12 or folic acid deficiency) often with considerable anisocytosis (with some microcytes present as well). In addition, macrocytes may be prominent in individuals with erythroleukemia, myelodysplastic disorders, acquired sideroblastic anemia, and with antimetabolite or androgen drug therapy. A lesser degree of macrocytosis is seen commonly in alcoholic patients. Polychromatophilic macrocytes usually indicate a high reticulocyte count.
Increased red cell distribution width (RDW) is seen in iron deficiency anemia and decreased or normal in thalassemia major (Cooley’s anemia), thalassemia intermedia
Anisocytosis with normal red blood cell size – Early iron, vit B12 or folate deficiency, dimorphic anemia, sickle cell disease, chronic liver disease, myelodysplastic syndrome.
|Red cell size as defined by MCV|
|RDW||Decreased (microcytic; low MCV)||Normal (normocytic; MCV = normal)||Increased (macrocytic; high MCV)|
|Normal (little or no anisocytosis)||Heterozygous thalassemias||Poor iron utilization||Liver disease|
|Acute blood loss||Aplastic anemia|
|Anemia of chronic disease (hypoproliferative)||Enzyme defects (e.g., G6PD deficiency)||Myelodysplastic syndrome|
|Increased (anisocytosis)||Iron deficiency||Early iron deficiency||Megaloblastic|
|Red cell fragmentation||Early megaloblastic||Sideroblastic|
|Myelophthisis||Secondary to chemotherapy|
|Sickle cell anemia|
|Secondary to chemotheraphy|
Footnote: a MCV may be falsely elevated due to cell agglutination, usually with cold agglutinins.
Abbreviations: Mean corpuscular volume (MCV); mean corpuscular hemoglobin (MCH); mean corpuscular hemoglobin concentration (MCHC)[Source 3) ]
Anisocytosis treatment involves treating the underlying causes e.g., thalassemia, iron deficiency anemia, sickle cell anemia, hemolytic anemia, pernicious anemia, chronic disease anemia, folate deficiency anemia, liver disease, etc.
It is essential that the underlying cause of the problem is identified so that correct treatment can begin.
Anisocytosis is often related to anemia and anemia is typically caused by iron or vitamin deficiency. The usual treatment for iron deficiency is taking iron supplements and changing the diet to increase iron levels through iron-rich foods. The most common supplement is ferrous sulfate, which is taken as a tablet.
References [ + ]
|1, 3.||↵||Sarma PR. Red Cell Indices. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 152. Available from: https://www.ncbi.nlm.nih.gov/books/NBK260|
|2.||↵||Lynch EC. Peripheral Blood Smear. In: Walker HK, Hall WD, Hurst JW, editors. Clinical Methods: The History, Physical, and Laboratory Examinations. 3rd edition. Boston: Butterworths; 1990. Chapter 155. Available from: https://www.ncbi.nlm.nih.gov/books/NBK263|